Myhep all tablet (Generic Epclusa) online in India
Myhep all tablet is a new generation medicine made by Mylan Pharmaceuticals that contains 2 active Generics – “Sofosbuvir and Velpatasvir”. The generic version of Epclusa is already available in 101 developing countries. Epclusa is the first “Hepatitis C treatment” that is registered for all 6 genotypes.
It is a combination of “VELPATASVIR & SOFOSBUVIR” of a fixed dose. Sofosbuvir is a direct active antiviral medication that works to stop the growth of hepatitis C Virus in the body and removing the virus from the blood. It helps your immune system fight the infection and may help your liver recover. It is prescribed a drug but needs a legal requirement from the HEPATOLOGIST or HCV treatment specialist. Food has no effect on the effectiveness of the drug.
To prevent the replication of the hepatitis C virus in the blood, the volume of “Sofosbuvir and Velpatasvir” is selected in an ideal ratio. Drug’s formula includes 2 active substances, which have a harmful effect on the causative agent of the disease. The medicine retains immunity and liver from the harmful effects of the virus.
Genotype and chronic of the disease
The Mixture is ideally suited to lead a patient to recover from hepatitis C 1, 2, 3, 4, 5, and 6 of the genotype and chronic of the disease. The Primary use for genotype 2 and 3 treatment (genotype 1 is a choice “Harvoni” “Epclusa”, or others).
It is manufactured by under the license of Gilead Sciences (producer of “Harvoni” and “Sovaldi”) The Sofosbuvir-Velpatasvir combo successfully cured Hepatitis C in 95-99% of patients with mild liver cirrhosis. Patients with moderate to severe cirrhosis experienced 94% of cure rate being on 12-week Epclusa regimen. The substances belong to the NS5B polymerase suppressor, which is necessary for hepatitis C virus for growth and development. Myhep all tablet is the 1st Hepatitis C drug that has a high cure rate for all (1-6) genotypes.
“Myhep all tablet” is known to very effective medicine which fights against Hepatitis C virus. The tablet may sometimes be used with another antiviral medication (ribavirin 200mg capsules).
Medicine should be taken in the dose and duration as advised by the doctor. Swallow it as a whole. Do not chew, crush or break it. Myhep all tablet is used to be taken at a fixed time. It can also be taken with or without consuming food. The jar in which the capsules packed is equipped with a screw capsule with the control of the first opening.
To make sure Myhep All is safe to use. The person needs to inform the doctor, if they have-
- A history of hepatitis
- Kidney disease (or if you are on dialysis)
- Liver problems other than hepatitis
- HIV (human immunodeficiency virus)
- Recent use of heart rhythm medicine called amiodarone.
MECHANISM OF ACTION
Myhep all tablet can be used alone or with “ribavirin” to treat and cure hepatitis C. It works and blocks the infection that causes hepatitis C from spreading inside the body.
Myhep All is likewise utilized with another antiviral pharmaceutical (ribavirin). Patients are advised to get a prescription from their doctor. Velpatasvir is an NS5A inhibitor which is utilized together with Sofosbuvir in the treatment of hepatitis C.
- The patient may feel uncomfortable, dizziness, blurred vision when the tablet is taken together with other medicines for the treatment of hepatitis c infection. And this may seriously affect the ability to drive.
- No dose adjustment of Myhep all tablet is recommended. Especially when used in patients with liver disease. Otherwise, Myhep all tablet is safe to use.
- Dose adjustment of Myhep all tablet may be needed in patients with severe kidney disease. So, it should be used with caution.
- One needs to take extreme care of female patients to avoid pregnancy.
- Most importantly use precautions while doing sexual contact, sharing needles, or contact with blood.
Take Myhep All exactly as prescribed by the doctor. One should not consume Myhep All in larger or smaller dosages/ quantities or for a duration longer than longer than recommended by their doctor.
IMPORTANT: PATIENTS ARE ADVISED TO CONSULT A DOCTOR IN ABOVE CASES.
Myhep all tablet Side Effects
Myhep all tablet “Side-effects” are possible but do not always occur. Some of the side-effects may be rare but serious. Epclusa has comparable “side effects” to other Hepatitis C treatment.
Common “Myhep all tablet side effects” may include:
To minimize the side effects, one must adhere to the treatment regimen and avoid overdose.
Hypersensitivity is a contraindication to Myhep all tablet. In addition, if a person is suffering from depression and kidney or liver problems, it is advised to ignore the use of Myhep all. In the taking of MYHEP all is prohibited in patients under 18 years of age. The treatment regimen for patients suffering from hepatitis C of all 6 genotypes is the same.
If there are contraindications to “ribavirin”, its use should be discarded. If there are contraindications to ribavirin, its use should be discarded.
It is very important to consult a doctor if you have Slow Heartbeats Rhythm, Weak or Shallow breathing, Low Red-blood Cells-Pale skin and Difficulty in Concentrating.
The doctor should be informed about patients the current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.) before using Myhep all tablet
If you feel Fatigue & Light-headed, Shortness of breath Chest Pain, Memory problems, Confusions and Other side effects, then it is advised to take medical help right away.
Do not expose the capsules to moisture or direct sunlight. Store the tablet at a temperature from+15°c to +30°c.
Myhep all tablet price in India
The cost of Epclusa in the “USA” is surprisingly $ 84,000.Besides that India has also done a wonderful job. They have created generic medicine for Hepatitis C and it helps many people to get treatment at almost 1% “cost” of USA and UK. Before buying online once check Myhep all “price” with competitors.
People may “buy” the medicine “online” in a very easy way with different kind of payment methods. The delivery will take at least 7-15 working days.